Strona główna・Stock List・Anika Therapeutics Inc

Anika Therapeutics Inc

Open

SectorHealthcare

21.48 2.33

Buy Sell

Overview

Share price change

24h

Current

Min

20.57

Max

21.87

Key metrics
By Trading Economics
Income	8.4M 3.3M
Sales	3M 33M
EPS	0.3
Profit margin	10.147
Employees	235
EBITDA	8.3M 4.9M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	-0.8% downside

Dividends
By Acuity
Next Earnings	4 lis 2026

Market Stats
By TradingEconomics
Market Cap	78M 277M
Previous open	19.15
Previous close	21.48

News Sentiment

By Acuity

50%

171 / 340 Ranking in Healthcare

Anika Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

13 sie 2026, 20:01 UTC

Anika Therapeutics Inc shares declined during Thursday's session, continuing a downward trend since Wednesday's close. No specific news was identified to explain the movement.

12 sie 2026, 19:51 UTC

Anika Therapeutics Inc is higher today, supported by positive sentiment from a recent inflation report, despite no specific company news identified.

11 sie 2026, 20:02 UTC

Anika Therapeutics Inc is trading higher, showing notable gains and peaking after an early dip, with no specific news identified to explain the movement.

10 sie 2026, 20:01 UTC

Anika Therapeutics shares declined during Monday's session, hitting a low of -3.68%, amid cautious investor sentiment following recent labor market data.

7 sie 2026, 20:03 UTC

Anika Therapeutics Inc shares are higher today, continuing a strong upward trend since Thursday's close amid broader market gains. No specific news was identified.

6 sie 2026, 20:02 UTC

Anika Therapeutics Inc. is trading higher Thursday, reflecting strong momentum despite a pullback from session highs. Broader economic data may influence investor sentiment.

5 sie 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, maintaining a gain above the 20-day moving average and near the upper end of the one-month range.

4 sie 2026, 19:51 UTC

Anika Therapeutics Inc. shares are lower today amid unusual volatility, despite a broader market reaction to declining crude oil prices.

3 sie 2026, 19:51 UTC

Anika Therapeutics Inc is sharply higher today, with no specific company news identified. Broader market dynamics, including falling oil prices, may be influencing performance.

31 lip 2026, 23:06 UTC

Anika Therapeutics Inc shares are higher in after-market trading, reflecting notable volatility earlier in the session and strong recent performance above the 20-day moving average.

30 lip 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, continuing a trend of five consecutive sessions of gains and maintaining strength above the 20-day moving average.

29 lip 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, amid notable volatility earlier. The stock remains above its 20-day moving average.

28 lip 2026, 19:36 UTC

Anika Therapeutics Inc shares are higher today, continuing a positive trend since Monday's close. The stock recently pulled back from earlier session highs.

27 lip 2026, 18:06 UTC

Anika Therapeutics Inc shares are higher Monday, reflecting a cumulative gain since Friday, amid broader market volatility influenced by declining oil prices.

24 lip 2026, 20:06 UTC

Anika Therapeutics Inc shares are higher today amid a positive market backdrop, despite some intraday volatility earlier in the session. No specific news was identified.

22 lip 2026, 20:13 UTC

Anika Therapeutics Inc. shares are lower in after-market trading, reflecting weak performance and broader market volatility amid rising crude oil prices.

21 lip 2026, 18:56 UTC

Anika Therapeutics Inc is trading higher, reflecting positive market sentiment, despite some intraday volatility earlier in the session. The stock remains elevated since Monday's close.

20 lip 2026, 19:06 UTC

Anika Therapeutics Inc shares are lower today, continuing a trend of declines over the past three sessions amid a broader market downturn in U.S. Treasuries.

Peer Comparison

Price change

Anika Therapeutics Inc Forecast

Price Target

By TipRanks

-0.8% downside

12 Months Forecast

Average 21 USD -0.8%

High 21 USD

Low 21 USD

Based on 2 Wall Street analysts offering 12 month price targets forAnika Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Anika Therapeutics Inc - Dist in the past 3 months.

Sentiment

By Acuity

171 / 340 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.